Abstract:Objective To investigate the clinical significance of pyrosequencing assay for determining K-ras mutations in exon 2 codons 12 and 13 in clinical colorectal cancer tissues.Methods Genomic DNA,extracted from K-ras mutant cell lines SW480 (homozygous,c.35G ＞ T), DLD-1 (heterozygous,c.38G ＞ A) and wild-type HT-29,was first used as the sequencing template respectively to test the accuracy of pyrosequencing methodology.The SW480 and DLD-1 DNA was separately mixed with wild-type HT-29 DNA in proportions of 2％,3％,5％,10％,20％,30％ and 50％,the sensitivity for mutation detection was measured separately by pyrosequencing assay and directed Sanger DNA sequencing in the serial DNA mixture samples.The pyrosequencing assay results were compared with the corresponding Sanger sequencing and the datas were analysized by Fisher exact test.Pyrosequencing analysis was then performed for screening K-ras exon 2 mutations at codons 12 and 13 on DNA isolated from a panel of 30 colorectal cancer samples derived from clinical formalin-fixed and paraffin embedded (FFPE)tissues.Results Cancer cell lines with known K-ras mutations ( SW480 and DLD-1 ) were readily detectable by pyrosequencing-based analysis.When the proportions of mutant colorectal cancer cell line DNA were 5％ and 10％ content,the mutation rates of K-ras gene detected by conventional Sanger DNA sequencing were 33.3％ (4/12) and 58.3％ (7/12) respectively,whereas the mutation rates detected by pyrosequencingbased assay were 91.7％ (11/12) and 100％ (12/12) respectively,there were significant differences between those two sequencing methodology ( P ＜0.05).Furthermore,we found 10 patients with K-ras exon 2 point mutations at codons 12 and 13 by pyrosequencing-based assay from 30 colorectal cancer FFPE tissues,the point mutation rate was 33.3％ (10/30) and all of the mutations determined were heterozygous.The codon 12 was most frequently affected [30％ (9/30)].Mutations with the highest frequency were G ＞ A transitions [ 50％ ( 5/10 ) ],followed by G ＞ T transversions [ 30％ ( 3/10 ) ].Conclusion The pyrosequencing assay provides an accurate and sensitive method for mutation screening of K-ras exon 2 codons 12 and 13 in routine diagnostic specimens,thereby allowing the selection of the cancer treatment in clinical individualized practice.

Sensitivity confirmation and assessment of the direct sequencing for the K-RAS gene in colorectal cancers

Values of Mutations of K-ras Oncogene at Codon 12 in Detection of Pancreatic Cancer: 15-Year Experience

Establishment of pyrosequencing method for detection of k-ras mutation

Genotyping of K-ras Exon 2 Codons 12 and 13 Mutations in Colorectal Cancer by Pyrosequencing

Direct Sequencing is a Reliable Assay with Good Clinical Applicability for KRAS Mutation Testing in Colorectal Cancer.

[Significance of K-ras Detection in Colorectal Cancer].

Detection of K-ras mutation in advanced colorectal carcinoma by Pyrosequencing

Detection of K-ras Mutation in Colorectal Cancer and Its Clinicopathological Significance

Detecting KRAS mutations in colorectal carcinoma patients with high resolution melting curve analysis

K-ras Point Mutation Detection in Colorectal Cancer:Comparison of Two Approaches Using Allele Specific Amplification

Detection of KRAS Mutations in Colorectal Cancer by High Resolu tion Melting Analysis

Detection of KRAS Mutation in Pancreatic Cancer and Colorectal Cancer Patients with Highly Sensitivite COLD-PCR

Detection of Low-Abundance KRAS Mutations in Colorectal Cancer Using Microfluidic Capillary Electrophoresis-Based Restriction Fragment Length Polymorphism Method with Optimized Assay Conditions.

[K-Ras Gene Mutation in Colorectal Cancer and Its Clinicopathologic Significance].

K-ras gene mutation status in 454 Chinese patients with colorectal cancer

Detection Of Kras Gene Mutations In Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy For Improving Pancreatic Cancer Diagnosis

Mutation Detection of K-ras Gene in Paraffin-Embedded Colorectal Cancer Tissues by Using Chip-Based TGCE

Comparative Analysis of Dideoxy Sequencing, the KRAS StripAssay and Pyrosequencing for Detection of KRAS Mutation.

KRAS Mutation Detection Method Based on LNA and Allele Specific Amplification

A Sensitive Assay Enriched with Blue/White Screening to Empower Sequencing Analysis for G > A Hotspot Mutation in Codon 13 of KRAS Gene

Rapid detection of K-ras oncogene point mutation by real-time fluorescence allele-specific amplification